Found 54 matching trials
A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLC PHASE2 This is a prospective, multi-center, single arm study assessing the efficac...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
Chemoradiotherapy With Surgery Followed by Consolidation Durvalumab PHASE4 Lung cancer presents a significant treatment challenge, particularly in the...
Show More Location
Amsterdam UMC, location VU Medical center
Learn More & Join Trial
Durvalumab and Consolidation SBRT Following Chemoradiation for Locally Advanced Stage III Non-Small Cell Lung PHASE2 Durvalumab is a drug that stimulates the immune system to fight lung cancer...
Show More Location
Rhode Island Hospital
Learn More & Join Trial
Durvalumab and Chemotherapy Induction Followed by Durvalumab and Radiotherapy in Large Volume Stage III NSCLC PHASE2 Standard treatment for stage III Non-Small Cells Lung Cancer (NSCLC) not el...
Show More Location
Gustave Roussy Institute
Learn More & Join Trial
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC) PHASE2 The purpose of this study is to determine whether JNJ-90301900 added to con...
Show More Location
Moores Cancer Center at UC San Diego Health
Learn More & Join Trial
SCION: SABR and Checkpoint Inhibition of NSCLC PHASE2 The SCION Trial is a clinical trial in patients with early stage non-small ...
Show More Location
BC Cancer--Kelowna
Learn More & Join Trial
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy PHASE3 This is a Phase III, Randomized, Double-blind, Placebo-controlled, Multi-ce...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Chemotherapy and Immunotherapy in Extensive-Stage Small-Cell Lung Cancer With Thoracic Radiotherapy PHASE2 This is a prospective, multi-centre, single arm, phase 2, open label clinic...
Show More Status
Active Not Recruiting
Location
Westmead Hospital
Learn More & Join Trial
Addition of Thoracic Consolidation Radiotherapy to the Maintenance Immunotherapy for ES-SCLC (STONE-001) PHASE3 This study is expected to enroll 182 patients with partial response or stab...
Show More Location
Multiple Locations
Learn More & Join Trial
Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC PHASE3 The purpose of this study is to test whether or not number of circulating c...
Show More Location
Stanford University
Learn More & Join Trial